Ernexa Therapeutics Inc. (ERNAW) Warrants
Each ERNAW warrant gives the holder the right to buy 1/25 share of Ernexa Therapeutics Inc. at $17.00 per share, until February 10, 2031. The stock last closed at $1.63, below the strike, so the warrant is out of the money. Ernexa Therapeutics Inc. has a market value of about $2.76M. There are 856.30K listed warrants; exercising all of them would add 2.0% to the 1.69M shares outstanding.
Ernexa Therapeutics Inc. reports its business to the SEC as “Pharmaceutical Preparations”, with its head office in Cambridge, MA; it is incorporated in Delaware. Its latest SEC filing was on November 19, 2026: current report (directors or officers changed), form 8-K. The warrant closed at $0.0326 on November 19, 2026, down 67% from $0.1000 on February 6, 2026. ERNA trades at 9.6% of the strike; it would have to rise about 10-fold to reach it.
Thinly traded: ERNAW traded about $99 a day over the last 30 days, and on only 15 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $17.00
- Shares per warrant
- 1/25
- Cash to exercise one warrant
- $0.6800
- Expiry
- 2031-02-10
- Redemption trigger
- none stated
- Cashless exercise
- no
- Break-even stock price
- $17.82
From the issuer's S-1/A (2026-02-05).
Exercise calculator
Each warrant buys 1/25 share at $17.00. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Ernexa Therapeutics Inc.
- Underlying stock
- ERNA
- Share price
- $1.63
- Market cap
- $2.76M
- Shares outstanding
- 1.69M
- 12-month range
- $1.62 – $37.00
- 12-month change
- -96%
- Value of all listed warrants
- $27.92K (1.0% of market cap)
- Industry
- Pharmaceutical Preparations
- Head office
- Cambridge, MA
- Incorporated in
- Delaware
Market cap is the last share price times shares outstanding (as of 2026-11-06). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
The stock is at 10% of the strike; this far from it the answer is mostly a guess about volatility.
- Last price
- $0.0326
- Low and high estimate
- $0.0011 – $0.0211
- Stock volatility, measured
- 147%
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- 122%
- Effect of dilution
- −0.4%
- Method
- exact Black-Scholes formula
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 1.69M
- Listed warrants
- 856.30K
- Dilution if all exercised
- 2.0%
Warrant count from the data the company files with the SEC.
Filings
- 8-KCurrent report: directors or officers changed
- 10-QQuarterly report
- 8-KCurrent report: investor update
- 8-KCurrent report: investor update
- 8-KCurrent report: directors or officers changed
- 10-QQuarterly report
- 8-KCurrent report: investor update
- 8-KCurrent report: shareholder vote results
- 8-KCurrent report: directors or officers changed
- DEFA14AMore proxy material
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
Questions about ERNAW
When does the ERNAW warrant expire?
ERNAW expires on February 10, 2031.
What is the strike price of ERNAW?
$17.00 per share; each warrant converts into 1/25 share, so exercising one warrant costs $0.6800.
Can Ernexa Therapeutics Inc. redeem the ERNAW warrants early?
The source filing we read lists no stock-price redemption trigger.
How many ERNAW warrants are outstanding?
856.30K listed warrants, equal to 2.0% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow ERNAW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

